Lupin launches Generic Ranolazine ER Tablets in US

28 Feb 2019 Evaluate

Lupin has launched Ranolazine Extended-Release (ER) Tablets, 500mg and 1000mg. The company’s Ranolazine ER Tablets, 500mg and 1000mg are a generic version of Gilead Sciences, Inc.'s Ranexa ER Tablets, 500mg and 1000mg. Ranolazine is indicated for the treatment of chronic angina.

Ranolazine ER Tablets, 500mg and 1000mg had an annual sales of approximately $ 945 million in the US (IQVIA MAT December 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2164.00 -25.75 (-1.18%)
13-Jan-2026 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.50
Dr. Reddys Lab 1187.55
Cipla 1443.10
Zydus Lifesciences 895.20
Lupin 2164.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×